These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 11694012)

  • 1. Scale-up feasibility in high-shear mixers: determination through statistical procedures.
    Iskandarani B; Shiromani PK; Clair JH
    Drug Dev Ind Pharm; 2001 Aug; 27(7):651-7. PubMed ID: 11694012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Process control in a high shear mixer-granulator using wet mass consistency: the effect of formulation variables.
    Faure A; Grimsey IM; Rowe RC; York P; Cliff MJ
    J Pharm Sci; 1999 Feb; 88(2):191-5. PubMed ID: 9950637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploration of melt granulation technique for the development of coprocessed directly compressible adjuvant containing lactose and microcrystalline cellulose.
    Gohe MC; Jogani PD
    Pharm Dev Technol; 2003; 8(2):175-85. PubMed ID: 12760568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scale-up studies on high shear wet granulation process from mini-scale to commercial scale.
    Aikawa S; Fujita N; Myojo H; Hayashi T; Tanino T
    Chem Pharm Bull (Tokyo); 2008 Oct; 56(10):1431-5. PubMed ID: 18827384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Applicability of a scale-up methodology for wet granulation processes in Collette Gral high shear mixer-granulators.
    Faure A; Grimsey IM; Rowe RC; York P; Cliff MJ
    Eur J Pharm Sci; 1999 May; 8(2):85-93. PubMed ID: 10210730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of process parameters on compressibility of granulation manufactured in a high-shear mixer.
    Badawy SI; Menning MM; Gorko MA; Gilbert DL
    Int J Pharm; 2000 Mar; 198(1):51-61. PubMed ID: 10722950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimization of operating conditions in a high-shear mixer using dem model: determination of optimal fill level.
    Terashita K; Nishimura T; Natsuyama S
    Chem Pharm Bull (Tokyo); 2002 Dec; 50(12):1550-7. PubMed ID: 12499588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is silicified wet-granulated microcrystalline cellulose better than original wet-granulated microcrystalline cellulose?
    Habib YS; Abramowitz R; Jerzewski RL; Jain NB; Agharkar SN
    Pharm Dev Technol; 1999 Aug; 4(3):431-7. PubMed ID: 10434289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of disintegrants on the properties of multiparticulate tablets comprising starch pellets and excipient granules.
    Mehta S; De Beer T; Remon JP; Vervaet C
    Int J Pharm; 2012 Jan; 422(1-2):310-7. PubMed ID: 22101283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Some variables influencing rotoagglomeration in the multiprocessor MP-1.
    Vetchý D; Rabisková M
    Int J Pharm; 2002 Aug; 242(1-2):353-6. PubMed ID: 12176278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compression parameters of hexagonal boron nitride on direct compression mixture of microcrystalline cellulose and modified starch.
    Halaçoğlu MD; Uğurlu T
    Pharm Dev Technol; 2015; 20(6):747-54. PubMed ID: 24841191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of high-shear granulation on granulate homogeneity.
    Vromans H; Poels-Janssen HG; Egermann H
    Pharm Dev Technol; 1999 Aug; 4(3):297-303. PubMed ID: 10434275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of starch 1500 as a binder and disintegrant in lamivudine tablets prepared by high shear wet granulation.
    Rahman BM; Ibne-Wahed MI; Khondkar P; Ahmed M; Islam R; Barman RK; Islam MA
    Pak J Pharm Sci; 2008 Oct; 21(4):455-9. PubMed ID: 18930870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Process optimization for continuous extrusion wet granulation.
    Tan L; Carella AJ; Ren Y; Lo JB
    Pharm Dev Technol; 2011 Aug; 16(4):302-15. PubMed ID: 20367553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Artificial Intelligence Tools for Scaling Up of High Shear Wet Granulation Process.
    Landin M
    J Pharm Sci; 2017 Jan; 106(1):273-277. PubMed ID: 27816264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of drug proportion and mixing time on the content uniformity of a low dose drug in a high shear mixer.
    Kornchankul W; Hamed E; Parikh NH; Sakr A
    Pharmazie; 2002 Jan; 57(1):49-53. PubMed ID: 11836931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An investigation on the correlation between drug dissolution properties and the growth behaviour of granules in high shear mixer.
    Guo Z; Ma M; Hao Y; Jiang T; Wang S
    J Pharm Pharmacol; 2011 Dec; 63(12):1548-58. PubMed ID: 22060285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of particle wall adhesion on particle electrification in mixers.
    Zhu K; Tan RB; Chen F; Ong KH; Heng PW
    Int J Pharm; 2007 Jan; 328(1):22-34. PubMed ID: 16930881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scale-up of high shear granulation based on the internal stress measurement.
    Watano S; Okamoto T; Sato Y; Osako Y
    Chem Pharm Bull (Tokyo); 2005 Apr; 53(4):351-4. PubMed ID: 15802830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-line monitoring of hydrate formation during wet granulation using Raman spectroscopy.
    Wikström H; Marsac PJ; Taylor LS
    J Pharm Sci; 2005 Jan; 94(1):209-19. PubMed ID: 15761944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.